Works matching IS 18379664 AND DT 2023 AND VI 14 AND IP 5


Results: 16
    1

    Survival of NSCLC Patients Treated with Cimavax-EGF as Switch Maintenance in the Real-World Scenario.

    Published in:
    Journal of Cancer, 2023, v. 14, n. 5, p. 874, doi. 10.7150/jca.67189
    By:
    • Flores Vega, Yoanna I.;
    • Páramo González, Diana L.;
    • Alsina Sarmiento, Sofía C;
    • Alsina Tul, Luis E.;
    • Inguanzo Valdés, Iris B.;
    • Rodríguez Machado, Jorge;
    • Larrinaga, Ángel Elejalde;
    • Flores Rodríguez, Justo E;
    • Lamadrid García, Janet;
    • Corrales Otero, Danay;
    • Ropero Toirac, Ramón;
    • Crombet Ramos, Tania;
    • Gracia Medina, Elias A.
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Prognostic Model of Baseline Medications plus Neutrophil-to-lymphocyte Ratio in Patients with Advanced Non-small-cell Lung Cancer Receiving Immune Checkpoint Inhibitor plus Platinum Doublet: A Multicenter Retrospective Study.

    Published in:
    Journal of Cancer, 2023, v. 14, n. 5, p. 676, doi. 10.7150/jca.80517
    By:
    • Izumi Nasu;
    • Masahiro Kondo;
    • Ryuji Uozumi;
    • Shinya Takada;
    • Shuichi Nawata;
    • Hirotoshi Iihara;
    • Yohei Okumura;
    • Masashi Takemoto;
    • Kozo Mino;
    • Tadanori Sasaki;
    • Chiemi Hirose;
    • Tohru Aomori;
    • Rena Shimano;
    • Ken Maeno;
    • Satoshi Oizumi;
    • Sojiro Kusumoto;
    • Yasushi Ohno;
    • Shinnosuke Ikemura;
    • Daiya Takai;
    • Azusa Hara
    Publication type:
    Article